The following video is from Tuesday's MarketFoolery podcast, in which host Chris Hill, along with analysts Jason Moser and Matt Argersinger, discuss the top business and investing stories of the day.
Johnson & Johnson (NYSE:JNJ) reported higher than-than-expected earnings. Shares of the consumer giant are up 28% in the past year. Will Johnson & Johnson continue to produce for investors? Should Johnson & Johnson follow Procter & Gamble's (NYSE:PG) lead and double down on some of its more profitable assets. In this installment of MarketFoolery, our analysts talk about the future of Johnson & Johnson.
The relevant video segment can be found between 10:34 and 17:01.
Chris Hill owns shares of Johnson & Johnson. Jason Moser and Fool contributor Matthew Argersinger have no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson and Procter & Gamble and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.